US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist

31.650
-0.090-0.28%

Close Mar 4 16:00 ET

33.000
+1.350+4.27%

Pre 04:05 ET

1.77BMarket Cap23.98P/E (TTM)

Supernus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 25, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	155.25M	174.16M	+18.91M
Beat Est.	-5.52%	+5.99%	+12.18%
EPS	0	0.27	+0.27
Beat Est.	-100.00%	+1450.57%	--

Analyst Rating

Buy

Feb 28, 2025

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 154.979M	--
--	2025/Q1	-- / 146.896M	--
Feb 25, 2025	2024/Q4	174.159M / 155.252M	--
Nov 4, 2024	2024/Q3	175.689M / 157.298M	--
Aug 6, 2024	2024/Q2	168.325M / 148.852M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 154.979M--

--2025/Q1-- / 146.896M--

Feb 25, 20252024/Q4174.159M / 155.252M--

Nov 4, 20242024/Q3175.689M / 157.298M--

Aug 6, 20242024/Q2168.325M / 148.852M--

Unlock Free Earnings Estimates

Open Account

Supernus Pharmaceuticals Earnings Reports

Supernus Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 25 16:16 ET

Supernus Pharmaceuticals | 8-K: Supernus Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 25 16:15 ET

Supernus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 4, 2024 16:24 ET

Supernus Pharmaceuticals | 8-K: Supernus Announces Third Quarter 2024 Financial Results

Nov 4, 2024 16:15 ET